FCB Health launches next-generation big data agency to better tell pharma brand stories

Advertising agency word cloud image
The FCB Health Network is wrapping big data capabilties from across its agencies to form a new data, analytics and media standalone agency, Solve(d). (Alpha Stock Images)

FCB Health wants to humanize data. While it’s been pushing that way for years, the network is formalizing that vision into a distinct agency called Solve(d).

The new agency brings together FCB Health Network capabilities and talent from data analytics, data science, customer relationship management and media. The 45-plus team is already up and running with clients, projects and data resources; FCB parent company IPG acquired first-party data giant Acxiom this summer.

RELATED: What's in a name? FCB Health's powerhouse shop Area 23 extends its brand power

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

“This has been our vision for the past five years or so, when we really started rounding out this capability overall. We started bringing in data scientists, marketing scientists, CRM specialists and then marrying it up with the organic media capability that had already been here for 40 years,” said Ken Beatty, Solve(d) managing director and FCB Health Network chief analytics officer.

The humanizing of data—not simplifying data or insights—is about making it understandable and useful in human decision-making.

“People usually don’t remember data or facts or figures; they remember the story that the data tells” said Michael Guarino, FCB Health Network chief commercial officer. “That’s what we’re trying to do here. Humanize that data to tell our brands’ stories in the most compelling way so that people not only remember them, but take action on them. That action could be going to a doctor, reading about a product or continuing to refill the medication they’re already on.”

RELATED: Lights, camera, action as FCB Health spins production studio into standalone shop

The Solve(d) logo mimics a mathematical equation, with the letters S-o-l-v-e above the line and the D below it.

Beatty said, “What I say is that the clients give us something to solve and we add the ‘d.’ We give them back something that is solved—something that they don’t have to interpret, and something [where] they don’t have to dig into sometimes very complex data to get to a resolution of their business challenge.”

Suggested Articles

Traditional generics bigwigs Teva, Mylan, Sandoz, Amneal and Endo have lost out to a group of six competitors in terms of U.S. weekly prescriptions.

Roche’s Tecentriq scored some big wins lately, including a pair of first-in-class approvals. But in other cancers, it's decided to pull the plug.

Biosims haven't worked, experts say. Instead, it's time to for an independent body to set fair biologic prices after the drugs lose exclusivity.